| # | Title | Journal | Year | Citations |
|---|
| 1 | Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection | Nature Medicine | 2021 | 3,133 |
| 2 | Global prevalence of injecting drug use and sociodemographic characteristics and prevalence of HIV, HBV, and HCV in people who inject drugs: a multistage systematic review | The Lancet Global Health | 2017 | 1,020 |
| 3 | Omicron extensively but incompletely escapes Pfizer BNT162b2 neutralization | Nature | 2022 | 928 |
| 4 | Epidemiology and natural history of HCV infection | Nature Reviews Gastroenterology and Hepatology | 2013 | 833 |
| 5 | Global, regional, and national incidence and mortality for HIV, tuberculosis, and malaria during 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013 | Lancet, The | 2014 | 786 |
| 6 | Spontaneous viral clearance following acute hepatitis C infection: a systematic review of longitudinal studies | Journal of Viral Hepatitis | 2006 | 715 |
| 7 | Estimation of stage-specific fibrosis progression rates in chronic hepatitis C virus infection: A meta-analysis and meta-regression | Hepatology | 2008 | 714 |
| 8 | Global statistics on alcohol, tobacco and illicit drug use: 2017 status report | Addiction | 2018 | 685 |
| 9 | Tuberculosis-associated immune reconstitution inflammatory syndrome: case definitions for use in resource-limited settings | Lancet Infectious Diseases, The | 2008 | 681 |
| 10 | mRNA vaccines induce durable immune memory to SARS-CoV-2 and variants of concern | Science | 2021 | 609 |
| 11 | Estimating progression to cirrhosis in chronic hepatitis C virus infection | Hepatology | 2001 | 526 |
| 12 | Meta‐analysis of drug‐related deaths soon after release from prison | Addiction | 2010 | 518 |
| 13 | The causal link between human papillomavirus and invasive cervical cancer: A population-based case-control study in colombia and spain | International Journal of Cancer | 1992 | 512 |
| 14 | Risk of cancer after low doses of ionising radiation: retrospective cohort study in 15 countries | BMJ: British Medical Journal | 2005 | 494 |
| 15 | Global burden of HIV, viral hepatitis, and tuberculosis in prisoners and detainees | Lancet, The | 2016 | 458 |
| 16 | Inflammation, Coagulation and Cardiovascular Disease in HIV-Infected Individuals | PLoS ONE | 2012 | 456 |
| 17 | Incidence and Risk Factors for New-Onset Diabetes in HIV-Infected Patients | Diabetes Care | 2008 | 448 |
| 18 | The Depsipeptide Romidepsin Reverses HIV-1 Latency In Vivo | PLoS Pathogens | 2015 | 445 |
| 19 | Aerosol transmission of SARS-CoV-2? Evidence, prevention and control | Environment International | 2020 | 439 |
| 20 | Mathematical assessment of the impact of non-pharmaceutical interventions on curtailing the 2019 novel Coronavirus | Mathematical Biosciences | 2020 | 438 |
| 21 | Neutralising antibody titres as predictors of protection against SARS-CoV-2 variants and the impact of boosting: a meta-analysis | Lancet Microbe, The | 2022 | 436 |
| 22 | Hepatitis C virus treatment for prevention among people who inject drugs: Modeling treatment scale-up in the age of direct-acting antivirals | Hepatology | 2013 | 431 |
| 23 | Simeprevir with pegylated interferon alfa 2a plus ribavirin in treatment-naive patients with chronic hepatitis C virus genotype 1 infection (QUEST-1): a phase 3, randomised, double-blind, placebo-controlled trial | Lancet, The | 2014 | 431 |
| 24 | Global patterns of opioid use and dependence: harms to populations, interventions, and future action | Lancet, The | 2019 | 404 |
| 25 | Humoral and circulating follicular helper T cell responses in recovered patients with COVID-19 | Nature Medicine | 2020 | 400 |
| 26 | VDJdb: a curated database of T-cell receptor sequences with known antigen specificity | Nucleic Acids Research | 2018 | 391 |
| 27 | Hepatocellular carcinoma risk following direct-acting antiviral HCV therapy: A systematic review, meta-analyses, and meta-regression | Journal of Hepatology | 2017 | 390 |
| 28 | Reduction of secondary transmission of SARS-CoV-2 in households by face mask use, disinfection and social distancing: a cohort study in Beijing, China | BMJ Global Health | 2020 | 382 |
| 29 | Airborne or Droplet Precautions for Health Workers Treating Coronavirus Disease 2019? | Journal of Infectious Diseases | 2022 | 382 |
| 30 | The present and future disease burden of hepatitis C virus (HCV) infection with today's treatment paradigm | Journal of Viral Hepatitis | 2014 | 372 |
| 31 | Accelerating the elimination of viral hepatitis: a Lancet Gastroenterology & Hepatology Commission | The Lancet Gastroenterology and Hepatology | 2019 | 370 |
| 32 | Major Clinical Outcomes in Antiretroviral Therapy (ART)–Naive Participants and in Those Not Receiving ART at Baseline in the SMART Study | Journal of Infectious Diseases | 2008 | 364 |
| 33 | Relative risk of cardiovascular disease among people living with HIV: a systematic review and meta‐analysis | HIV Medicine | 2012 | 346 |
| 34 | Viral suppression and HIV transmission in serodiscordant male couples: an international, prospective, observational, cohort study | Lancet HIV,the | 2018 | 337 |
| 35 | Global, regional, and country-level coverage of interventions to prevent and manage HIV and hepatitis C among people who inject drugs: a systematic review | The Lancet Global Health | 2017 | 334 |
| 36 | Alterations in the Immune Response of Human Immunodeficiency Virus (HIV)-Infected Subjects Treated with an HIV-Specific Protease Inhibitor, Ritonavir | Journal of Infectious Diseases | 1996 | 332 |
| 37 | Prevalence and pattern of neuropsychological impairment in human immunodeficiency virus–infected/acquired immunodeficiency syndrome (HIV/AIDS) patients across pre- and post-highly active antiretroviral therapy eras: A combined study of two cohorts Clinical Report | Journal of NeuroVirology | 2004 | 330 |
| 38 | The effects of female sex, viral genotype, andIL28Bgenotype on spontaneous clearance of acute hepatitis C virus infection | Hepatology | 2014 | 320 |
| 39 | Evolution of immune responses to SARS-CoV-2 in mild-moderate COVID-19 | Nature Communications | 2021 | 316 |
| 40 | Predicting the risk of cardiovascular disease in HIV-infected patients: the Data collection on Adverse Effects of Anti-HIV Drugs Study | European Journal of Cardiovascular Prevention and Rehabilitation | 2010 | 309 |
| 41 | Life expectancy of HIV‐positive people after starting combination antiretroviral therapy: a meta‐analysis | HIV Medicine | 2017 | 309 |
| 42 | The global epidemiology and burden of opioid dependence: results from the global burden of disease 2010 study | Addiction | 2014 | 308 |
| 43 | The use of the Framingham equation to predict myocardial infarctions in HIV-infected patients: comparison with observed events in the D:A:D Study | HIV Medicine | 2006 | 296 |
| 44 | Prevalence of scabies and impetigo worldwide: a systematic review | Lancet Infectious Diseases, The | 2015 | 285 |
| 45 | Sexual negotiation in the AIDS era | Aids | 1997 | 267 |
| 46 | Glecaprevir and pibrentasvir yield high response rates in patients with HCV genotype 1–6 without cirrhosis | Journal of Hepatology | 2017 | 261 |
| 47 | Levels of Human Immunodeficiency Virus Type 1 RNA in Cerebrospinal Fluid Correlate with AIDS Dementia Stage | Journal of Infectious Diseases | 1997 | 259 |
| 48 | Phase 2 gene therapy trial of an anti-HIV ribozyme in autologous CD34+ cells | Nature Medicine | 2009 | 259 |
| 49 | AIDS dementia complex and HIV-1 brain infection: Clinical-virological correlations | Annals of Neurology | 1995 | 257 |
| 50 | Liposomal amphotericin B (AmBisome) compared with amphotericin B both followed by oral fluconazole in the treatment of AIDS-associated cryptococcal meningitis | Aids | 1997 | 252 |
